Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Junko S. Takeuchi"'
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Maki Konishi, Junko S. Takeuchi, Kumi Horii, Mitsuru Ozeki, Haruhito Sugiyama, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Longitudinal data are lacking to compare booster effects of Delta breakthrough infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron. Methods Participants were the staff of a national research and me
Externí odkaz:
https://doaj.org/article/d0605f87e451440196f540c6a5afcbf1
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 347-354 (2023)
Objectives: To investigate the role of immunogenicity after the third vaccine dose against Omicron infection and COVID-19-compatible symptoms of infection. Methods: First, we examined vaccine effectiveness (VE) of the third dose against the second do
Externí odkaz:
https://doaj.org/article/fec3573d884a494d9dd25717a6e815d2
Autor:
Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Azusa Kamikawa, Yumiko Kito, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract The humoral and cellular immune responses against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) upon the coronavirus disease 2019 (COVID-19) vaccination remain to be clarified. Hence, we aimed to investigate the long-term chro
Externí odkaz:
https://doaj.org/article/7b66c86b6e6542ae9c3f1916ebc675d9
Autor:
Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S. Takeuchi, Noriko Tomita, Kouki Matsuda, Kenji Maeda, Shohei Yamamoto, Ami Fukunaga, Norio Ohmagari, Ayako Mikami, Kengo Sonoda, Mugen Ujiie, Hiroaki Mitsuya, Wataru Sugiura
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 1 (2023)
Although vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease 2019 (COVID-19) induce effective immune responses, vaccination with booster doses is necessary because of waning immunity. We conducted an open-label, non-rand
Externí odkaz:
https://doaj.org/article/9e1eb62a8e1847b9bf4013d1581744ff
Autor:
Kei Yamamoto, Yusuke Ohsiro, Tetsuya Suzuki, Michiyo Suzuki, Sayaka Miura, Maki Nagashima, Noriko Iwamoto, Junko S. Takeuchi, Moto Kimura, Wataru Sugiura, Satoru Nebuya, Masato Kurokawa, Norio Ohmagari
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Although biomarkers to predict coronavirus disease 2019 (COVID-19) severity have been studied since the early pandemic, no clear guidelines on using them in clinical practice are available. Here, we examined the ability of four biomarkers to predict
Externí odkaz:
https://doaj.org/article/f31cbb10602d4b5d8ba5804d64e73b74
Autor:
Yuriko Terayama, Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, Junko S. Takeuchi, Yuki Takamatsu, Kenji Maeda, Ayako Mikami, Mugen Ujiie, Wataru Sugiura
Publikováno v:
Life, Vol 12, Iss 7, p 966 (2022)
Background: The coronavirus disease 2019 (COVID-19) pandemic is currently ongoing, and there have been significant efforts in the development of COVID-19 vaccines. However, the neutralizing antibody titers in vaccinated individuals are reported to pr
Externí odkaz:
https://doaj.org/article/f4aefdb744314301915d5bf6b6e077a2
Autor:
Seik-Soon Khor, Yosuke Omae, Junko S. Takeuchi, Ami Fukunaga, Shohei Yamamoto, Akihito Tanaka, Kouki Matsuda, Moto Kimura, Kenji Maeda, Gohzoh Ueda, Tetsuya Mizoue, Mugen Ujiie, Hiroaki Mitsuya, Norio Ohmagari, Wataru Sugiura, Katsushi Tokunaga
Publikováno v:
Vaccines, Vol 10, Iss 4, p 563 (2022)
BNT162b2, an mRNA-based SARS-CoV-2 vaccine (Pfizer-BioNTech, New York, NY, USA), is one of the most effective COVID-19 vaccines and has been approved by more than 130 countries worldwide. However, several studies have reported that the COVID-19 vacci
Externí odkaz:
https://doaj.org/article/0d6c9d5dbde64d188211cb2d406f7525
Autor:
Satomi Mitsuhashi, Kirill Kryukov, So Nakagawa, Junko S. Takeuchi, Yoshiki Shiraishi, Koichiro Asano, Tadashi Imanishi
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Abstract We developed a portable system for 16S rDNA analyses consisting of a nanopore technology-based sequencer, the MinION, and laptop computers, and assessed its potential ability to determine bacterial compositions rapidly. We tested our protoco
Externí odkaz:
https://doaj.org/article/2c6889f8575c4b71aad55cf5bac500bf
Autor:
So Nakagawa, Toshiaki Katayama, Lihua Jin, Jiaqi Wu, Kirill Kryukov, Rise Oyachi, Junko S Takeuchi, Takatomo Fujisawa, Satomi Asano, Momoka Komatsu, Jun-ichi Onami, Takashi Abe, Masanori Arita
Publikováno v:
Genes & Genetic Systems; Oct2023, Vol. 98 Issue 5, p221-237, 17p
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Junko S. Takeuchi, Yunfei Li, Maki Konishi, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Shinichi Oka, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
ImportanceInvestigating the role of pre-infection humoral immunity against Omicron BA.5 infection risk and long COVID development is critical to inform public health guidance.ObjectiveTo investigate the association between pre-infection immunogenicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10c57d8f3ba834f49178db614c6cc661
https://doi.org/10.1101/2023.04.05.23288162
https://doi.org/10.1101/2023.04.05.23288162